chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received Moderna as her first two vaccines and got the Pfizer booster as her third vaccine. Patient did not have any adverse reactions to the booster and was told to contact us if she started experiencing any side effects.
pt recv vax & hips & knees ache an excruciating pain;pt suffered this same pain off & on sense 5yrs old started as rxn to polio shot;arthritis is best term pt can use to describe the pain;pt is worst 2 days p/IPV vax;
Both my grown children got the flu after getting the flu shots ten or fifteen years ago; Initial information was received on 14-Oct-2021 regarding an unsolicited valid non-serious social media case received from a consumer/non-healthcare professional.  This case involves 2 children of unknown gender who had "both my grown children got the flu after getting the flu shots ten or fifteen years ago" (influenza), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patients developed non-serious "both my grown children got the flu after getting the flu shots ten or fifteen years ago" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Hello, The following potential adverse event has been found on a public post for Flu Shot page. Since this is a public post on the Sanofi flu shot campaign Flu Shot Fridays we are assuming the consumer is referring to the Sanofi flu vaccine. I do not care. Stop with the propaganda. Both my grown children got the flu after getting the flu shots ten or fifteen years ago.So nobody in this family gets the flu shot or this vaccine."  It was unknown if the patients experienced any additional symptoms/events.  Details of laboratory data were not reported.  It was not reported if the patients received any corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on the lot number for this case.
On Jan 25th, 2021 patient went to the Covid clinic to get the first dose of covid vaccine at 5:50 pm. After receiving the vaccine , patient was advised to wait at the waiting room to watch for any adverse reactions.  Around 6:05 pm patient had a seizure and was around by the hospital staffs. The rapid response team came and took the patient to the Emergency Department on a wheelchair. Patent was alert when she left the Covid clinic.
Left shoulder with 12x9cm erythematous area that is warm and slightly swollen.  No fluctuance or abscess present.  No streaking up arms.
Symptoms progressed through the evening of the injection. Began with left arm pain within a few hours. Body Aches and chills began approximately 4 hours after injection. Fever peaked at 104.6 that night. Also experienced fatigue and weakness. Fever was gone after 2 days and other symptoms greatly reduced, with some lingering fatigue for a few more days.
Hives on left eyelid, left cheek, some on neck and upper chest; Itchy roof of mouth; Watery eyes; Slight tingly sensation on scalp; Severe sneezing; Sore throat; Congestion; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 18Apr2021 at 14:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included fibrous displaysea. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously took sulfers and 10/30-hackensack ER/IV vancomycin (antibiotic) 1g dose (MANUFACTURE UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 19Apr2021 the patient experienced congestion and headache. On 20Apr2021 at 12:00, the patient experienced hives on left eyelid, left cheek, some on neck and upper chest, itchy roof of mouth, watery eyes, slight tingly sensation on scalp, severe sneezing and sore throat. The events resulted in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were taken as a result of congestion, headache, hives on left eyelid, left cheek, some on neck and upper chest, itchy roof of mouth, watery eyes, slight tingly sensation on scalp, severe sneezing and sore throat that included treatment with over the counter Claritin D (MANUFACTURER UNKNOWN) and Tylenol (MANUFACTURER UNKNOWN) from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events congestion, headache, hives on left eyelid, left cheek, some on neck and upper chest, itchy roof of mouth, watery eyes, slight tingly sensation on scalp, severe sneezing and sore throat were resolving at the time of report. No follow-up attempts are needed. No further information is expected.
eyelids at the bottom are both watery; slight fever; pains and needles all over my body; right arm felt so heavy; it was swollen; lost taste buds; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (right arm felt so heavy), PERIPHERAL SWELLING (it was swollen), LACRIMATION INCREASED (eyelids at the bottom are both watery), PARAESTHESIA (pains and needles all over my body) and AGEUSIA (lost taste buds) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In October 2021, the patient experienced AGEUSIA (lost taste buds). On 18-Oct-2021, the patient experienced LIMB DISCOMFORT (right arm felt so heavy), PERIPHERAL SWELLING (it was swollen) and PARAESTHESIA (pains and needles all over my body). On 19-Oct-2021, the patient experienced LACRIMATION INCREASED (eyelids at the bottom are both watery) and PYREXIA (slight fever). In October 2021, PERIPHERAL SWELLING (it was swollen) had resolved. On 18-Oct-2021, LIMB DISCOMFORT (right arm felt so heavy) had resolved. On 19-Oct-2021, PARAESTHESIA (pains and needles all over my body) and PYREXIA (slight fever) had resolved. At the time of the report, LACRIMATION INCREASED (eyelids at the bottom are both watery) and AGEUSIA (lost taste buds) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that patient had right arm swelling lasted for 3 to 4 days. Event pains and needles all over patients body after the first shot and it was only the first and second night, first night was only at the feet and then second night was up to the eyes.  Company Comment: This case concerns a 54-year-old female patient, with unknown medical history, who experienced the non-serious unexpected AESI of AGEUSIA. The event occurred in an unknown date, approximately two weeks after receiving the first dose Moderna COVID 19 vaccine. The rechallenge is not applicable since the event occurred after the first dose and it has not recovered. The benefit-risk relation of the Moderna COVID 19 vaccine is unaffected by this report. no concomitants drugs were reported. no treatment drugs were reported. Second shot due on 15Nov2021.; Sender's Comments: This case concerns a 54-year-old female patient, with unknown medical history, who experienced the non-serious unexpected AESI of AGEUSIA. The event occurred in an unknown date, approximately two weeks after receiving the first dose Moderna COVID 19 vaccine. The rechallenge is not applicable since the event occurred after the first dose and it has not recovered. The benefit-risk relation of the Moderna COVID 19 vaccine is unaffected by this report.
Patient received Moderna immunization for dose #2 on 3/11/21, when he should have received Pfizer.
Information was received from a consumer who was providing follow-up to her daughter's case (MARRS# 1410USA010376). The consumer reported that her daughter's friend, age and additional demographics were not provided, also received GARDASIL 2 doses with same lot number (K001500 exp 06-NOV-2016) as her daughter. The patient received this at the same physician's office. Her first dose was on 11-JUL-2014. The patient experience bruising with that dose. Dose 2 was given (date not provided) and the patient experienced unspecified problems and then developed low platelets. Treatment and outcome were not provided. The consumer reported that the girl's mother would report the event as well. This is one of several reports from the same source. Additional information has been requested.
Hives appeared roughly 1 hour after injection and persisted for following three days. Heart discomfort (fluttering with some mild pain) and circulation issues appeared starting about 1 week after injection - still persistent.
sore arm; Initial information was received on 10-Oct-2021 regarding an unsolicited valid non-serious social media  case from a consumer/non-healthcare professional.  This case involves adult female patient who had sore arm (pain in extremity), after receiving INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included COVID-19 VACCINE for immunisation.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious sore arm (pain in extremity) (unknown latency) for a couple of days following the administration of INFLUENZA VACCINE.  It was reported "hello, The following potential adverse event has been found on a public post for Flu Shot on social media. Since this is a public post on the social media we are assuming the consumer is referring to the Sanofi flu vaccine. I recently got flu shot. I got covid booster last week. It did not cause side effects like the first 2. Only sore arm a couple of days."  It was unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  It was not reported if the patient received any corrective treatment for the event.  On an unknown date, the patient was recovered from the reported event.  There will be no information available on the lot number for this case.
Flu symptoms severe two days then fatigue, malaise on-going on day 4. Arm swelling pain and itching on-going day 4. Rash spreading currently 6inches by 10 inches around injection site.
Left thigh swollen, with tenderness. No erythemia. Left knee painful- increased pain with weight bearing. Left side of face swollen todya. No fever 98.6.
Inconsolable crying x 4 hours, prompting ER visit.  LLQ tenderness on exam.  Suspected intussusception.
Pfizer-BioNTech COVID- 19 Vaccine EUA: During the post-vaccination observation period, vaccine recipient experience an allergic reaction. They developed throat closing, angioedema, and perioral cyanosis. They were treated by EMS on site with epinephrine, diphenhydramine, methylprednisolone, ondansetron, and normal saline fluids. They were transported to emergency department. During reexamination, the patient?s symptoms improved and they were discharged to home.
The pt experienced generalized hives covering the body beginning approximately 1 hour post vax with itching and redness. The pt reportedly took over the counter Benadryl, the redness was partially relieved. The pt began to break out again this time in less than 2 hours; redness covered the arms, back, face, neck and legs. Reportedly the pt was sent to their PMD. Atarax, and a topical cream was prescribed. Reportedly the pt recovered from this experience. Follow-up #1 28-Jul-2002: During internal review of all files, it was deemed necessary to amend the report by updating the Adverse Event coding (added rash).
Swollen, sore, warm, pink where shot was given.  Swollen to an oval about 3 in long. Diagnosed with cellulitis.  Treated with antibiotic for 10 days.
Patient states she started feeling unwell (dizzy, lightheaded, nauseous) soon after sitting in observation area. Applied cool pack to neck and put patient in wheelchair. EMT's present took patient's vital signs which were normal. Patient also developed a tight cough and stated she had a pressure of heaviness in her chest. Vital signs remained unchanged. Called 911, O2 applied at 2L . When medic arrived- assessed patient, obtained EKG which was normal and offered pt. transport to ER but also stated pt. could go home as she did not appear to be having a severe reaction. Instructed pt. to call 911 for additional symptoms. Pt. refused transport. Pt. said the nausea comes/goes but she feels good enough to leave. Accompanied pt, along with husband to exit.
Information has been received from a Nurse Practitioner concerning an 18 year old female patient who on 17-MAR-2010 was vaccinated intramuscularly with the third 0.5 ml dose of GARDASIL (lot # 0981Y). Concomitant therapy included LOESTRIN 24 FE. On 01-APR-2010, the patient developed a lump on her arm and it was hot and red and it was the size of an egg. The patient went to the office on 20-APR-2010 for treatment and was also experienced pain and had limited rage of motion. At the time of the report the patient had not recovered. Follow up information has been received from a Nurse Practitioner who reported that on 01-APR-2010, the student developed a lump on the left deltoid at the injection site. There was swelling and sensitivity. The patient also had pain and arm raises. The patient was treated with KEFLEX 500 mg twice a day for 10 days and with MOTRIN 800 mg every 8 hours per necessity. At the time of the report it was unknown if the patient recovered. No further information is available.
10-8-14 approximately noon -> dizzy/HA/nausea. 10-8-14 approximately 9 pm -> cramp, diarrhea, cold, dizzy, shaking, hives, flu-like symptoms.
suspected vaccination failure; 15 people I have spoken to who said they experienced shingles / all of them say they got it after; This case was reported by a consumer via ( interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient received Shingles vaccine and experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. This case was one of the 16 cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR088476: US-GLAXOSMITHKLINE-US2021AMR088498:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088500:Original Case : US2021AMR088476 US-GLAXOSMITHKLINE-US2021AMR088499:
(L) arm pain, radiating from shoulder down to hand. Began after vaccine and continuing (1 month). MD visit required. Patient says now taking anti-inflammatory medication.
INDIVIDUAL MAGNETIZED; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced individual magnetized. The action taken with covid-19 vaccine was not applicable. The outcome of individual magnetized was not reported.  This report was non-serious.
Initial information was received from a health care professional on 09 October 2008. A 35 year old pregnant female with no reported obstetric history received a right deltoid injection of ADACEL (lot number C2767AA) on 22 September 2008. It was not known whether the patient experienced any adverse events. The patient's date of her last menstrual period was 05 September 2008. The patient's estimated date of confinement was not reported. No further information was provided. Follow-up information was received 15 December 2008 from a health care professional who stated that they had no additional information regarding this patient and provided the contact information for the patient's OB/GYN. Follow-up information was received from another health care professional on 19 March 2009. The patient had not been vaccinated at that facility, and the reporter had no information regarding vaccination. The patient had begun care at the facility on 10 October 2008, and per the reporter the patient's due date was 10 October 2009. No additional information was provided. Follow up information was received from another health care professional on 23 March 2009. The patient had a miscarriage on 14 October 2008. No further information was provided. Based upon this new information received, this case meets seriousness criteria and has been upgraded to serious. Documents held by sender: None.
Narrative: Per DOD records: pt. " with diffuse urticaria predominantly on chest, back, scalp, and pruritus fingers and toes daily if not taking Allegra. Widespread urticaria first presented after Covid booster shot in December 2021. Patient states hives occur every day if Allegra is not taken. Patient denies any Known allergies and does not take any other medication other than Allegra. Urticaria is not exercise induced. " Also noted 12/27/21 DOD note that indicated rash started after patient started wearing a metal necklace.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown demographics. Patients' pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. On multiple unspecified dates these patients were vaccinated with improperly stored doses of ROTATEQ, (lot# L048854 and expiry date 31-AUG-2017) (strength, dosing details, route and anatomical location were unknown). No adverse effects were reported. No product quality complaint was involved. This is one of the 3 reports received from reporter source. Additional information has been requested.
Pt w/ PMH significant for positive PPD in 2019. 13mins post vaccination pt c/o Dizziness. Vitals: @17:42 BP103/47, HR 67, RR 21, O2 Sat 100% -- > @17:52 110/69, 63, 18, 100% PT given H2O and taken to Med Room via WC to lay down. VS taken and WDL. Apple juice given. Dr and family at bedside. PT reported no dizziness and denied other symptoms and stated he was feeling better. PT educated, ambulated independently with steady gait. Left building accompanied by family. NAD.
Patient is under the age of 18. Currently, the Moderna COVID-19 vaccine has been indicated for those of 18 years of age and older. There has not been any adverse effects with the patient other than being under the age clinically indicated. The patient is 16 years old so is recommended to finish the 2-dose series in 4 weeks.
Information has been received from a health care professional concerning a 12 year old male who on 10/28/91 was vaccinated with 1 dose of MMR and subsequently, the pt "broke out in typical measles type rash several days after vaccination with fever of 102F." On 11/5/91, the pt was seen by a physician and was dx'd with measles. The pt recovered after 9 days. Additional information has been requested.
Bruising  and irritation of injection site, no further adverse effects noted by the patient. She showed me her bruise on 9/23/21 and I told her to monitor it and if it gets worse to contact her PCP.
Elevated blood pressure, swelling and redness in upper arm, warm to touch, rash on entire left arm, extreme pain radiating down arm including some tightness, pain radiating up  to shoulder and neck, stiffness in neck and shoulder, numb/tingly feeling in just above the elbow down to my fingertiips, redness to face.  Went to hospital May 29th diagnosed with allergic reaction and infection.  Placed on Benadryl, steroid and doxycycline for 7 days.   Returned to urgent care per doctors office on June 25th and was told infection still existed. Placed on Benadryl, steroid and doxycycline again.   Admitted to hospital June 28th for IV treatment for the infection.  referred to dr/neurologist for the numb/tingly feeling in arm/hand.  Dr believes the needle struck/knicked my nerve.  Believe there is additional inflammation to the nerve and needs to be further evaluated.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. No medical history and concurrent conditions were reported. On an unknown date the patients were vaccinated with improperly stored GARDASIL 9 (incorrect product storage) (lot # L023230, expiry date 26-JUL-2017) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. The action taken with the therapy with GARDASIL 9 was unknown. There was no product quality complaint reported. It was reported that the vaccines were exposed to a temperature of 32.4 degrees Fahrenheit for a cumulative total of 13 hours. This is one of the 3 reports from the same source. Additional information has been requested.
Patient was to receive the Pfizer updated bivalent booster but the vaccine was given without the diluent. Patient received a concentrated dose of the booster; 0.2ml of undiluted vaccine was administered. Family member, who also works in the pharmacy, called later that evening to report she remembered not diluting the vial before she told the technician to draw up 0.2ml for the dose. I advised her to monitor for any allergic reaction and educated her on possible adverse reactions that could occur. No adverse reactions were reported as of two days post vaccination.
The following morning my right deltoid was swollen, hard, very sore, and hot to touch. Within two hours later I began running a fever and the pain began to radiate up my neck and to my ear. In the early afternoon, my vision was somewhat blurred and I began to have nausea, fever/chills, and headache. "Bruised" feeling muscle pain, hard, swollen, and hot to touch right deltoid continued until 01/01/2019.